#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8440	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2721	750.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1740	1740	C	981	C,A	889,4	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	8440	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2721	750.2	0	HET	.	.	.	C207T,A	.	207	207	C	763	763	C	833	C,T,A	577,161,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14150	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4195	817.5	0	.	n	.	0	T695C	SNP	695	695	T	1409	1409	C	1104	C,T,A,G	1000,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14150	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4195	817.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2352	2352	G	947	G,A,T	635,237,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14150	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4195	817.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2685	2685	C	994	C,G,A	893,4,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14150	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4195	817.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2759	2759	A	984	A,T	885,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14150	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4195	817.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3311	3311	C	1022	C,G	941,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	882	folP	855	855	100.0	folP.l6.c17.ctg.1	1997	107.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1237	1239	AGC	126;125;125	A;G;C	114;116;114	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4084	102.5	1	SNP	p	S91F	1	.	.	271	273	TTC	891	893	TTC	118;120;120	T,A;T;C	103,1;102;111	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4084	102.5	1	SNP	p	G95N	0	.	.	283	285	GGC	903	905	GGC	121;123;123	G;G;C	110;114;112	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1734	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4084	102.5	1	SNP	p	D95G	1	.	.	283	285	GGC	903	905	GGC	121;123;123	G;G;C	110;114;112	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	696	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	2100	81.6	1	SNP	p	G45D	0	.	.	133	135	GGC	775	777	GGC	158;158;158	G;G;C	138;140;142	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	508	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1581	77.1	0	.	n	.	0	A197.	DEL	197	197	A	893	893	A	152	A,C	142,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1724	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3571	116.9	1	SNP	p	D86N	0	.	.	256	258	GAC	937	939	GAC	130;130;141	G;A,G;C	110;99,1;125	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1724	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3571	116.9	1	SNP	p	R87I	0	.	.	259	261	CGT	940	942	CGT	139;141;144	C;G;T	124;117;118	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1724	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3571	116.9	1	SNP	p	R87W	0	.	.	259	261	CGT	940	942	CGT	139;141;144	C;G;T	124;117;118	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1724	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3571	116.9	1	SNP	p	S87R	1	.	.	259	261	CGT	940	942	CGT	139;141;144	C;G;T	124;117;118	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1724	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3571	116.9	1	SNP	p	S88P	0	.	.	262	264	TCC	943	945	TCC	144;143;143	T;C;C	129;130;133	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1470	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3331	107.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1897	1899	GGC	113;116;116	G;G;C	104;103;104	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1412	1414	GCC	218;218;218	G,A;C,A;C,A	191,1;192,1;192,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1415	1417	ATG	218;218;213	A,G,T,C;T;G,C	190,1,1,1;193;187,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1427	1429	ACC	217;217;217	A;C;C	190;190;190	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1427	1429	ACC	217;217;217	A;C;C	190;190;190	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1928	1930	ACC	183;182;179	A;C,A;C,A	166;160,1;166,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1982	1984	GCG	181;181;181	G,T;C,A,T,G;G,C,T	155,1;134,1,1,1;151,1,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1982	1984	GCG	181;181;181	G,T;C,A,T,G;G,C,T	155,1;134,1,1,1;151,1,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2105	2107	GGT	139;138;136	G,T;G,T,A;T,G	128,1;121,5,1;122,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2114	2116	AGC	121;120;120	A,G;G;C,A,G	97,2;104;101,1,2	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1600	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2531	150.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2132	2134	CCG	104;103;103	C;C,T;G,C	88;80,2;84,3	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	2324	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3668	150.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1881	1883	CCG	218;217;217	C,G,T;C,T;G,C,T,A	174,4,1;192,1;161,5,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	716	porA	1146	1146	99.91	porA.l15.c17.ctg.1	2540	68.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	881	881	C	71	C	59	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1032	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2033	120.4	1	SNP	p	G120K	1	.	.	358	360	AAG	847	849	AAG	140;142;144	A,C;A;G	133,1;134;135	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1032	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2033	120.4	1	SNP	p	A121N	1	.	.	361	363	AAC	850	852	AAC	145;144;144	A;A;C,A	136;138;133,2	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1032	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2033	120.4	1	SNP	p	N121D	0	.	.	361	363	AAC	850	852	AAC	145;144;144	A;A;C,A	136;138;133,2	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3994	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5354	180.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	584	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1487	95.5	1	SNP	p	V57M	1	.	.	169	171	ATG	751	753	ATG	192;191;192	A;T;G	178;179;180	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
